Related Experiment Videos
[Can gentamicin nephrotoxicity in rats be modified by chronic administration of muzolimine?]
Abstract:
Some loop diuretics seem to increase gentamicin nephrotoxicity. We investigated this property for a new diuretic, muzolimine, in female Wistar rats. Each rat was given gentamicin intraperitoneally in a dosage that induces morphological and functional modifications in the kidneys (20 mg/kg/day for 7 days). Muzolimine was given in a daily dosage of 15 mg/kg starting 15 days before the first gentamicin injection and continuing throughout the seven-day gentamicin course. As compared to controls given gentamicin alone, modifications induced by the muzolimine-gentamicin combination showed no significant differences for the following criteria: renal accumulation of gentamicin, membrane lysosomal latency, renal oxidative mitochondrial metabolism and cortical activity of renal cathepsin B, N-acetyl-beta-D-glucosaminidase (NAG) and alanine aminopeptidase. However, slightly lower sphingomyelinase activities (p less than 0.05) were found for muzolimine + gentamicin as compared to gentamicin alone. Urinary NAG excretion increase more with muzolimine + gentamicin than with gentamicin alone, perhaps as a result of the very significant increase in urinary output observed with the diuretic. Our results show that, in contrast to findings with another loop diuretic, furosemide, the renal toxicity of gentamicin is not noticeably modified by concomitant administration of muzolimine.
Insights
Muzolimine does not increase gentamicin nephrotoxicity in rats. This study found no significant differences in kidney damage markers when muzolimine was administered with gentamicin, unlike other loop diuretics.
Area of Science:
- Pharmacology
- Nephrology
- Toxicology
Context:
- Gentamicin, an aminoglycoside antibiotic, is known for its potential nephrotoxicity.
- Certain loop diuretics have been implicated in exacerbating gentamicin-induced kidney damage.
- Muzolimine is a newer loop diuretic whose interaction with gentamicin nephrotoxicity has not been extensively studied.
Purpose:
- To investigate whether muzolimine, a loop diuretic, influences gentamicin nephrotoxicity in a rat model.
- To compare the effects of muzolimine and gentamicin co-administration with gentamicin alone on renal parameters.
Summary:
- Female Wistar rats received gentamicin (20 mg/kg/day for 7 days) with or without muzolimine (15 mg/kg/day starting 15 days prior).
- Key indicators of kidney damage, including gentamicin accumulation, lysosomal latency, mitochondrial metabolism, and specific enzyme activities (cathepsin B, N-acetyl-beta-D-glucosaminidase (NAG), alanine aminopeptidase), showed no significant differences between groups.
- Slightly reduced sphingomyelinase activity and increased urinary NAG excretion were observed in the muzolimine + gentamicin group, potentially linked to diuretic-induced diuresis.
Impact:
- The findings suggest that muzolimine does not enhance gentamicin nephrotoxicity, contrasting with observations for other loop diuretics like furosemide.
- This research provides valuable data for clinicians regarding the potential co-administration of muzolimine and gentamicin.
- Further investigation may clarify the mechanisms behind altered sphingomyelinase activity and urinary NAG excretion in the presence of muzolimine-induced diuresis.